Target intelligence / Profile preview

Composite endogenous growth factor network (CEGFN)

Target
CEGFN
Molecular classification
Other
01

Overview

The composite endogenous growth factor network is a conceptual framework representing the complex, interconnected signaling pathways involving various growth factors such as VEGF, FGF, PDGF, and TGF-beta. These factors work in concert to regulate fundamental cellular processes including proliferation, differentiation, and survival. In a physiological context, this network is essential for tissue repair, embryonic development, and maintaining homeostasis. However, dysregulation of this network is a hallmark of many diseases, particularly cancer, where overactive signaling drives tumor growth and metastasis. Because it describes a broad biological system rather than a single molecular entity, it is not considered a discrete therapeutic target, although individual components within the network are frequently targeted by specific inhibitors or monoclonal antibodies.

Other names
Endogenous growth factor signaling networkGrowth factor signaling pathwaysGrowth factor interactome
02

Mechanism of action

Not applicable as this is a conceptual network of multiple signaling molecules rather than a single drug target.

03

Biological functions

Cell proliferationCell differentiationAngiogenesisWound healingSignal transductionTissue regeneration
04

Disease associations

CancerFibrosisCardiovascular diseaseDiabetes mellitusNeurodegenerative disease
05

Safety considerations

Off-target effects due to network complexitySystemic toxicity from multi-pathway inhibitionCompensatory signaling leading to drug resistance

Beyond the preview

Go deeper on Composite endogenous growth factor network (CEGFN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Composite endogenous growth factor network (CEGFN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call